Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FGFR2 translocation
i
Other names:
FGFR2, BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25, Fibroblast growth factor receptor 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2263
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
(2)
News
Trials
Search handles
Search handles
Filter by
Latest
almost3years
FGFR2 translocations are present in 15% of intrahepatic cholangiocarcinomas. A major milestone was the FDA approval of FGFR inhibitors in cholangiocarcinoma. The first FGFRi approved was pemigatinib. @gaboualfa @miteshborad @doccatenacci https://t.co/jxHi6czZix (12/n) (@clearyonc)
almost 3 years ago
FDA event
|
FGFR2 (Fibroblast growth factor receptor 2)
|
FGFR2 translocation
|
Pemazyre (pemigatinib)
almost3years
A few weeks ago, a 2nd FGFR inhibitor, Infigratinib (BGJ398), was FDA approved for patients with cholangiocarcinoma harboring an FGFR2 translocation. @JavleMilind @rachnatshroff @MiteshBorad @DrElkhoueiry @GABOUALFA @GIcancerDoc https://t.co/3gkw9jRPiN #TumorBoardTuesday (13/n) (@clearyonc)
almost 3 years ago
Clinical • FDA event
|
FGFR2 (Fibroblast growth factor receptor 2)
|
FGFR2 translocation
|
Truseltiq (infigratinib)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login